Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Phenytoin products are in shortage in Canada (1 of 6 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Sep 1, 2026.
An anticonvulsant used to control seizures in epilepsy.
Products affected
1 / 6
In shortage since
Mar 31, 2026
Est. full return
Sep 1, 2026
Reports on file
27
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
PHENYTOIN SODIUM INJECTION USP
50MG · SOLUTION · HIKMA CANADA LIMITED
DIN 02431378 · since Mar 31, 2026, est. end Sep 1, 2026 · Delay in shipping of the drug.
Resolved
DILANTIN
100MG · CAPSULE · BGP PHARMA ULC
DIN 00022780 · ended Apr 21, 2026 · Demand increase for the drug.
Resolved
PHENYTOIN SODIUM
100MG · CAPSULE · AA PHARMA INC
DIN 02460912 · ended May 15, 2026 · Disruption of the manufacture of the drug.
Resolved
PHENYTOIN SODIUM
100MG · CAPSULE · AA PHARMA INC
DIN 02460912 · ended Jan 19, 2026 · Disruption of the manufacture of the drug.
Resolved
DILANTIN
100MG · CAPSULE · BGP PHARMA ULC
DIN 00022780 · ended Jan 6, 2026 · Disruption of the manufacture of the drug.
Resolved
PHENYTOIN SODIUM
100MG · CAPSULE · AA PHARMA INC
DIN 02460912 · ended Oct 29, 2025 · Disruption of the manufacture of the drug.
Resolved
DILANTIN
100MG · CAPSULE · BGP PHARMA ULC
DIN 00022780 · ended Sep 12, 2025 · Quality Hold
Resolved
DILANTIN
30MG · CAPSULE · BGP PHARMA ULC
DIN 00022772 · ended Aug 8, 2025 · Quality Hold
Resolved
PHENYTOIN SODIUM
100MG · CAPSULE · AA PHARMA INC
DIN 02460912 · ended Jan 21, 2025 · Disruption of the manufacture of the drug.
Resolved
PHENYTOIN SODIUM
100MG · CAPSULE · AA PHARMA INC
DIN 02460912 · ended Nov 26, 2024 · Disruption of the manufacture of the drug.
Resolved
PHENYTOIN SODIUM
100MG · CAPSULE · AA PHARMA INC
DIN 02460912 · ended Jul 30, 2024 · Disruption of the manufacture of the drug.
Resolved
DILANTIN
30MG · CAPSULE · BGP PHARMA ULC
DIN 00022772 · ended Mar 7, 2024 · Disruption of the manufacture of the drug.
Showing 12 of 27 reports. All reports are on file with Health Canada.
What's happening
Phenytoin is currently affected by an active shortage report filed with Health Canada by HIKMA CANADA LIMITED.
The reported cause is: delay in shipping of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Phenytoin is classified under “ANTIEPILEPTICS” (ATC N03AB).
Recent changes
No changes recorded yet.
Common questions
What is Phenytoin used for?
An anticonvulsant used to control seizures in epilepsy.
When will Phenytoin be back in stock in Canada?
The latest manufacturer estimate is Sep 1, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Phenytoin in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Possible alternatives in the same class (antiepileptics)
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.